Serum amyloid A for predicting prognosis in patients with newly diagnosed Crohn’s disease
Although causality was not found, baseline SAA level was an independent predictor of surgery and disease progression in newly diagnosed CD, and had additive benefit to existing prediction models.
Authors
- Pinwei Huang
- Yizhe Tie (ORCID: https://orcid.org/0000-0002-4804-0218)
- Kelvin Y. Xie (ORCID: https://orcid.org/0000-0001-8675-5321)
- Shenghong Zhang (ORCID: https://orcid.org/0000-0002-9088-8781)
- Rirong Chen (ORCID: https://orcid.org/0000-0002-8230-1995)
- Xi Zhang (ORCID: https://orcid.org/0000-0002-4524-2084)
- Liqian Zhang (ORCID: https://orcid.org/0000-0002-4102-6675)
- Jianwu Zhang (ORCID: https://orcid.org/0000-0001-5628-4928)
- Minhu Chen
- Li Li
- X. Tang
- Zhirong Zeng
- Qia Chen
Institutions
- Sun Yat-sen University (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- First People's Hospital of Nanning (CN)
Publication Details
- Journal
- BMJ Open Gastroenterology
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1136/bmjgast-2024-001497
- Citations
- 1
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.23
Funders
- National Natural Science Foundation of China
- Guangdong Science and Technology Department